QIAGEN OmicSoft and Biomedical Knowledge Base

Checkpoint inhibitors in the context of biomarkers, drug targets and pathways

211 views
May 11, 2023
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.

In this training, you’ll learn how to:

· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases

· Derive a biomarker/gene signature from a specific condition (for example, non-responders of a drug, or a particular disease/disease subtype and others)

· Correlate expression of multiple genes and biomarkers

· Compare different experimental groups (e.g., your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity

Related videos

QIAGEN OmicSoft and Biomedical Knowledge Base

Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...

1,989 views July 19, 2022

High-quality biomedical relationships knowledge is the cornerstone of modern...

QIAGEN OmicSoft and Biomedical Knowledge Base

Supercharge your AI in drug discovery with high-quality biomedical data

658 views October 11, 2023

If you’re working in pharma or biotech, you likely rely on artificial...

QIAGEN OmicSoft and Biomedical Knowledge Base

Unlocking the power of API-based 'omics queries

591 views June 12, 2023

If you're a data scientist or bioinformatician working in biopharma, here's...

QIAGEN OmicSoft and Biomedical Knowledge Base

Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation

482 views September 19, 2023

If you’re a data scientist or bioinformatician working in biopharma and need...